AUGO affiliate files to sell 55,000 shares
AUGO affiliate reports proposed sale of 55,000 shares of Common Stock.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
AUGO affiliate reports proposed sale of 55,000 shares of Common Stock. The filing lists the securities to be sold as 55,000 shares (acquired upon option exercise on 03/05/2021). The filing also discloses recent dispositions by the holder: 10,000 shares on 03/17/2026, 10,000 on 03/18/2026, 10,000 on 03/19/2026, 5,000 on 03/20/2026, and 188,000 shares on 05/11/2026.
Insights
Notice of proposed resale under Rule 144 with listed prior sales.
The filing provides a Rule 144 notice for 55,000 shares described as acquired upon an option exercise on 03/05/2021. It also itemizes multiple recent dispositions by the reporting holder, including a 188,000-share sale on 05/11/2026.
Timing and proceeds treatment are not detailed in the excerpt; compliance with holding-period and manner-of-sale requirements will determine whether these shares may be sold under Rule 144 without registration.
Large recent disposals by the holder are visible; market impact depends on trading context.
The excerpt lists five discrete dispositions in March–May 2026, culminating with a 188,000-share sale. The proposed sale of 55,000 shares is recorded separately as securities to be sold.
Whether these transactions affect supply depends on the identity and liquidity of the holder and market conditions; the filing itself does not state how sales were executed.
Key Figures
Key Terms
Form 144 regulatory
option exercise financial
securities to be sold regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does AUGO's Form 144 disclose?
Who is the reporting holder in this Form 144 for AUGO?
Are the past sales and the proposed sale the same in the filing?
Does the Form 144 state how proceeds will be used?
When were the securities to be sold acquired?
AI-generated analysis. How Rhea-AI works. Not financial advice.